dancergirl56
About
Sorafenib maintenance throughout sufferers together with FLT3-ITD severe myeloid leukaemia going through allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised period Three tryout.
Sorafenib maintenance throughout sufferers together with FLT3-ITD severe myeloid leukaemia going through allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised period Three tryout.